Statements and Guidelines
The College's statements and guidelines inform the highest standard of clinical practice by our specialists.| Title | Notes | Category | Type | View | hf:tax:statement-guideline-type | hf:doc_categories |
|---|---|---|---|---|---|---|
| A Practitioner’s Toolkit for Managing Menopause (Monash University) | Gynaecology | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Antenatal Corticosteroids Given to Women Prior to Birth to Improve Fetal, Infant, Child and Adult Health (Liggins Institute) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Assessment of Competency (C-Gen 9) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Birth After Caesarean (C-Obs 38) | August 2025 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Caesarean Birth on Maternal Request CBMR (C-Obs 39) | 2023 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Care in Labour in the Absence of Pregnancy Complications (C-Obs 31) | 2023 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Categorisation of Urgency for Caesarean Section (C-Obs 14) | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Cervical Cancer Screening in Australia and Aotearoa New Zealand (C-Gyn 19) | Signposting 2024 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Clinical Guideline for Abortion Care | 2023 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Care Around Stillbirth and Neonatal Death Clinical Practice Guideline (Stillbirth CRE & PSANZ) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Handover (WPI 19) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Clinical Training Whilst Pregnant (C-Trg 7) | TV | TV Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Communication Between Eligible Midwives and Obstetricians (GP or Specialist) (ACM) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | ||
| Consent and Provision of Information to Patients in Australia Regarding Proposed Treatment (C-Gen 2a) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Consent and Provision of Information to Patients in New Zealand Regarding Proposed Treatment (C-Gen 2b) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Contraception Clinical Guideline (C-Gyn 3) | 2024 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Cross-Border Reproductive Care (C-Gyn 36) | 2021 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Credentialing in Obstetrics and Gynaecology (WPI 23) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Cultural Competency (WPI 20) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Delivery of Fetus at Caesarean Birth (C-Obs 37) | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Decision Aids to Accompany Fatigue Risk Management in Obstetric and Gynaecological Practice (WPI 18) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Cultural Safety Statement of Intent | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Diagnosis and Management of Suspected Fetal Macrosomia (C-Obs 65) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Early Pregnancy Screening and Prevention of Preterm Preeclampsia and Related Complications (C-Obs 61) | 2024 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Driving after Abdominal Surgery Including Caesarean Section (C-Gen 21) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Australian Living Evidence Guideline: Endometriosis | 2025 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Exercise During Pregnancy (C-Obs 62) | 2020 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Fatigue Risk Management in Obstetric and Gynaecological Practice (WPI 18) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Evidence-based Medicine, Obstetrics and Gynaecology (C-Gen 15) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies (SOGC) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Female Genital Mutilation (FGM) (C-Gyn 1) | 2023 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Genetic Carrier Screening (C-Obs 63) | Interim Update Jul 2024 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Fibroids in Infertility (C-Gyn 27) | 2018 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Guidance for Healthy Weight Gain in Pregnancy (Ministry of Health NZ) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Guidelines for Human Papillomavirus (HPV) Vaccine (C-Gyn 18) | Signposting 2024 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Guidelines for Appointment of Obstetricians and Gynaecologists to Specialist Positions in Australia and New Zealand (WPI 17) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Guidelines for the Use of Rh(D) Immunoglobulin (Anti-D) in Obstetrics (C-Obs 6) | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Guidelines for Performing Gynaecological Endoscopic Procedures (C-Trg 2) | TV | TV Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Guidelines for Patient Record Management on the Discontinuation of Practice (WPI 8) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Guidelines for Scanning of Live Subjects for Teaching Purposes (WPI 21) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Gynaecological Examinations and Procedures (C-Gyn 30) | 2020 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Guidelines for Training in Advanced Endoscopic Surgery (C-Trg 1) | TV | TV Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Guidelines for Visiting Surgeons Conducting Demonstration Sessions (C-Gen 6) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Home Births (C-Obs 2) | 2023 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Instrumental Vaginal Birth (C-Obs 16) | 2020 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Intrahepatic Cholestasis of Pregnancy (RCOG Green-top Guideline No. 43) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Interview and Selection of Obstetricians and Gynaecologists for Visiting Medical Officers, Salaried Medical Officers and Academic Staff in Australia (WPI 4) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Intrapartum Fetal Surveillance (IFS) (C-Obs 1) (Version 5.1) | March 2026 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Investigation of Intermenstrual and Postcoital Bleeding (C-Gyn 6) | 2021 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Joint RANZCOG/ANZCA/RACGP Position Statement on the Provision of Obstetric Anaesthesia and Analgesia Services (WPI 14) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Locum Positions in Specialist Obstetric and Gynaecological Practice in Australia and New Zealand (WPI 12) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Management of Breech Presentation (C-Obs 11) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Gestational Trophoblastic Disease (C-Gyn 31) | 2017 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Management of Hepatitis C in Pregnancy (C-Obs 51) | 2020 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Monochorionic Twin Pregnancy (C-Obs 42) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Obesity in Pregnancy (C-Obs 49) | 2022 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Perinatal Infections (ASID) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Management of Postpartum Haemorrhage (PPH) (C-Obs 43) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Managing Menopausal Symptoms (C-Gyn 9) | Under Review 2020 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Maternal and Perinatal Data Collection (C-Obs 40) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Maternal Group B Streptococcus in Pregnancy Screening and Management (C-Obs 19) | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Managing the Adnexa at the Time of Hysterectomy for Benign Gynaecological Disease (C-Gyn 25) | 2023 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Measurement of Cervical Length for Prediction of Preterm Birth (C-Obs 27) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Obstetric and Gynaecology Services in Rural and Remote Regions in Australia (C-Obs 34) | 2020 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Placenta Accreta Spectrum (PAS) (C-Obs 20) | 2023 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS) | Gynaecology | Relevant External Resource | useful-clinical-guidance | statements-guidelines-gynaecology statements-guidelines | ||
| Performance of Sexual Assault Forensic Examinations by RANZCOG Trainees (C-Gen 12) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Polypropylene Vaginal Mesh Implants for Vaginal Prolapse (C-Gyn 20) | 2021 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Position Statement on Midurethral Slings (C-Gyn 32) | 2020 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Position Statement on Breastfeeding and Lactation in the Workplace | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29) | March 2026 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Power Morcellation at Minimally Invasive Procedures (C-Gyn 33) (Previously “Tissue Extraction”) | 2022 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Position Statement on the Appropriate Use of Diagnostic Ultrasound (C-Gen 10) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Pre-Pregnancy and Pregnancy Related Vaccinations (C-Obs 44) | Signposting Interim Update Oct 2024 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Pre-Pregnancy Counselling (C-Obs 3a) | 2024 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Prevention and Management of Postpartum Haemorrhage (RCOG Green-top Guideline No. 52) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Prevention of Congenital Cytomegalovirus (CMV) Infection (C-Obs 64) | Interim Update July 2023 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Prevention, Detection, and Management of Subgaleal Haemorrhage in the Newborn (C-Obs 28) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Progesterone Use in the Second and Third Trimester of Pregnancy for the Prevention of Preterm Birth (C-Obs 29b) | 2017 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Prophylactic Antibiotics in Obstetrics and Gynaecology (C-Gen 17) | 2021 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| TV Training Registrar Supervision Guideline (C-Trg 5) | TV | TV Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| TV Position Statement Health of Women Seeking Asylum, Refugees and Women Held in Detention | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| TV Wellbeing Position Statement | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Responsibility for Neonatal Resuscitation at Birth (C-Obs 32) | Interim Update Mar 2023 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Reproductive Health for Women with an Intellectual Disability (C-Gyn 10) | 2021 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Routine Antenatal Assessment in the Absence of Pregnancy Complications (C-Obs 3b) | 2022 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Screening and Diagnosis of Fetal Structural Anomalies and Chromosome Conditions (C-Obs 35) | 2024 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Sacrocolpopexy Clinical Guidance Statement (C-Gyn 37) | 2022 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Shoulder Dystocia (RCOG Green-top Guideline No. 42) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Semi-Retired RANZCOG Fellow (WPI 24) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Shared Maternity Care in Australia (WPI 9) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Sexuality-Related Communication (WHO) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | ||
| Stand-Alone Primary Midwifery-Led Units (WPI 15) | Workforce and Practice Issues | TV Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Statement on Climate Change (2019) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Statement on Prolonged Exposure to Bushfire Smoke and Poor Air Quality (2020) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Subclinical Hypothyroidism and Hypothyroidism in Pregnancy (C-Obs 46) | 2022 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Substance Use in Pregnancy Clinical Guideline (C-Obs 53) | 2024 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Term Prelabour Rupture of Membranes (Term PROM) (C-Obs 36) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Tamoxifen and the Endometrium (C-Gyn 12) | 2019 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Surrogacy in Australia and New Zealand (C-Gen 16) | General | TV Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| The Initial Management of Chronic Pelvic Pain (RCOG Green-top Guideline No. 41) | Gynaecology | Relevant External Resource | useful-clinical-guidance | statements-guidelines-gynaecology statements-guidelines | ||
| The Management of Third and Fourth Degree Perineal Tears (RCOG Green-top Guideline No. 29) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| The Management of Women with Red Cell Antibodies During Pregnancy (RCOG Green-top Guideline No. 65) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| The Prevention and Elimination of Disrespect and Abuse During Facility-based Childbirth (WHO) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | ||
| Third Trimester Fetal Growth Scan Reporting Template | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Timing of Planned Caesarean Section at Term (C-Obs 23) | 2022 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Umbilical Cord Prolapse (RCOG Green-top Guideline No. 50) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Use of Prostaglandins for Induction of Labour (C-Obs 22) | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Use of Lasers in Obstetrics and Gynaecology (C-Trg 4) | TV | TV Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Use of the Veress Needle to Obtain Pneumoperitoneum Prior to Laparoscopy (C-Gyn 7) | 2021 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Uterine Artery Embolisation for the Treatment of Uterine Fibroids (C-Gyn 23) | 2020 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Vaginal Rejuvenation and Cosmetic Vaginal Procedures (C-Gyn 24) | 2019 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Vasa Praevia (C-Obs 47) | July 2025 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Vitamin and Mineral Supplementation and Pregnancy (C-Obs 25) | 2019 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Water Immersion During Labour and Birth (C-Obs 24) | 2021 | Obstetrics | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) | 2025 | Gynaecology | TV Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Australasian Diabetes in Pregnancy Society (ADIPS) 2025 Consensus Recommendations for the Screening, Diagnosis and Classification of Gestational Diabetes | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Guideline on the Prophylactic Use of Rh-D Immunoglobin in Pregnancy Care | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Perinatal Mental Health Clinical Practice Guideline (Centre of Perinatal Excellence – COPE) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Position Statement: Reusable Surgical Gowns (Royal Australasian College of Surgeons) | Gynaecology, Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Guideline: Smoking Cessation in Pregnancy and Breastfeeding (Quit Victoria) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Hypertension in Pregnancy Guideline (SOMANZ) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Guideline on Procedural Sedation (ANZCA) | Gynaecology, Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | ||
| Cervical Screening Guidelines and Endorsement (Cancer Council Australia) | Gynaecology | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Managing Infant Formula Donations, Procurement and Distribution in Emergencies (Australian Breastfeeding Association) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Vitamin D Deficiency Guideline (Te Whatu Ora) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| National Recommendations for Rare Disease Health Care (Rare Disease Awareness, Education, Support and Training RArEST Project) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Australian Evidence-Based Guideline for Unexplained Infertility (NHMRC) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Indications for Pharmacogenomic Testing (RCPA) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Guideline for Newborn Screening for Spinal Muscular Atrophy (UNSW) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Assessment and Management of Abnormal Uterine Bleeding (AUB) in Non-Pregnant Women of Reproductive Age (Health New Zealand – Te Whatu Ora) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| ARF/RHD Guidelines (Menzies School for Health Research) | Gynaecology | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Premature Ovarian Insufficiency Guideline (ESHRE) | Gynaecology | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Anti-Mullerian Hormone (AMH) Testing (University of Sydney) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Supporting Diverse Families: Clinical Staff Resources (Red Nose) |
| Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |
| Clinical Practice Guideline for Neonatal Hypoglycaemia (University of Auckland) | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Implanon NXT® (etonogestrel) Subdermal Implant Training Recommendations for Healthcare Professionals in Australia |
| Gynaecology, Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | |
| Australian Clinical Guidelines on HTLV-1 for Aboriginal Primary Health Care Settings | Obstetrics | TV Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Standards For Australian Secondary Fracture Prevention Services (SOSFA) | General | TV Endorsed | ranzcog-endorsed | statements-guidelines-general statements-guidelines |
Disclaimer
TV reviews clinical guidelines, statements, and patient information pamphlets on a five-year rotation, notwithstanding special circumstances. The number of documents that require review in any given year is large and on occasion we are unable to complete all of them within the designated time frame. Some of these documents will not require updating at the time they are reviewed. In these cases, the version date and year for next review will be updated, but the content remains unchanged.
The ‘due for review date’ on a document is an administrative tool that helps us to keep track of our information resources. It does not mean that the information is no longer relevant once the review date has passed. The information within these documents does not expire, but changes to treatments, practices and advice can change over time, which is why RANZCOG regularly reviews and updates them (if necessary). The information provided in these documents is of a general nature and should not be seen as a substitute for medical advice or assessment by a doctor. An individual’s specific circumstances should always be considered when medical decisions are made.
TV will prioritise information for review if the circumstances warrant it.
Request archived documents
Complete the request form for archived statements and guidelines. Please note that requests can take 5-10 days to complete.